NPPB and hydrops fetalis: In brief, adult HF patients, regardless of LVEF, in NYHA functional class III with either a HF-related hospitalization or persistently elevated NT-proBNP levels, who were treated with optimal doses of GDMT for a minimum of 3 months, were eligible for inclusion.